Advertisement

Topics

Clovis looks for new drugs after Rubraca success

06:40 EDT 20 Jun 2017 | pharmaphorum

Clovis Oncology is in bullish mood following strong results from a late-stage study of ovarian cancer treatment Rubraca. Once tipped to be an also-ran, new phase 3 results for the drug now make it a contender against its rivals in the burgeoning ...

Original Article: Clovis looks for new drugs after Rubraca success

NEXT ARTICLE

More From BioPortfolio on "Clovis looks for new drugs after Rubraca success"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...